HONG KONG SAR – Media OutReach Newswire – 12 May 2025 – 0xmd, a global startup specializing in Generative Artificial Intelligence for healthcare, has formed a strategic partnership with SENAI CIMATEC, one of Brazil’s foremost technology and innovation institutions. This agreement initiates 0xmd’s operations in Brazil, extending the company’s footprint within the Latin American market. Through this collaboration, 0xmd will introduce its advanced AI technologies to Brazil, including automated clinical exam analysis, medical image interpretation, and conversational diagnostic support solutions. This partnership establishes 0xmd as the first international healthtech firm to integrate with CIMATEC’s innovation ecosystem. With established operations in the United States and China, 0xmd aims to advance healthcare access democratization in Brazil by delivering intelligent tools that assist medical professionals in diagnosis, treatment planning, and personalized patient care. A distinctive feature of 0xmd’s technology is its deployment of medical and healthcare large language models featuring natural language interfaces—such as clinical chatbots—that enable smooth interaction between healthcare providers and decision-support systems. “Partnering with SENAI CIMATEC allows 0xmd to tailor its solutions for the Brazilian market and amplify its regional impact, ” stated Allen Au, Chairman & Chief Architect of 0xmd.

“SENAI CIMATEC’s strong reputation in innovation and research makes it the ideal collaborator to help us navigate Brazil’s healthcare landscape and ensure successful integration of our technology. ” The initial project phase will concentrate on adapting 0xmd’s technology to Brazilian regulatory requirements and integrating it with local healthcare systems. This partnership also addresses the growing demand for AI solutions in healthcare, especially in areas such as image-based diagnostics, clinical report automation, and personalized therapies. This collaboration with SENAI CIMATEC underscores 0xmd’s dedication to expanding its global influence and fostering healthcare innovation. (https://www. 0xmd. com)